DianaELakeMD

Associate Professor, Medicine, Weill Cornell Medical College

Overview of Dr. Lake

Dr. Diana Lake is a hematologist in West Harrison, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Phelps Memorial Hospital Center. She received her medical degree from Chicago Medical School/Rosalind Franklin University of Medicine Science and has been in practice 45 years. Dr. Lake accepts several types of health insurance, listed below. She is one of 61 doctors at Memorial Sloan Kettering Cancer Center and one of 3 doctors at Phelps Memorial Hospital Center who specialize in Hematology. She has more than 50 publications and over 500 citings.

Office
500 Westchester Avenue
West Harrison, NY 10604
Book by Phone+1(470) 375-1112

Education & Training

Seton Hall University-Hackensack Meridian School of MedicineFellowship, Hematology, 1980 - 1980
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1976 - 1980
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1975 - 1976
Maimonides Medical CenterResidency, Internal Medicine, 1974 - 1975
New York Presbyterian Hospital (Cornell Campus)Residency, Pathology-Anatomic and Clinical, 1973 - 1974
Michael Reese Hospital and Medical CenterInternship, Transitional Year, 1972 - 1973
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1972

Certifications & Licensure

NY State Medical License 1976 - 2026
NJ State Medical License 1980 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow (FACP) American College of Physicians, 1997
Super Doctor SuperDoctors.com

Clinical Trials

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
Completed
Phase 3
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2009 May 15
Active, not recruiting
Phase 2
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3

Publications & Presentations

PubMed

85 citations
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer.
Komal Jhaveri, Sarat Chandarlapaty, Diana Lake, Teresa Gilewski, Mark E. Robson
Clinical Breast Cancer. 2014-06-01
450 citations
Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assi...
Andrew D. Seidman, Donald A. Berry, Constance Cirrincione, Lyndsay Harris, Hyman B. Muss
Journal of Clinical Oncology. 2008-04-01
61 citations
Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized, Double-Blind, Placebo-Cont...
Harold J. Burstein, C. Cirrincione, William T. Barry, Helen K. Chew, Sara M. Tolaney
Journal of Clinical Oncology. 2014-12-10

Press Mentions

How MSK Treats Patients 65 and Older with Breast CancerSeptember 8th, 2023

Professional Memberships

American College of Physicians - ACP
Fellow

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment